甲强龙联合低分子肝素治疗原发性肾病综合征临床分析

目的 观察甲基强的松龙＋低分子肝素治疗原发性肾病综合征的临床疗效。方法 选取肾病综合征患者56例,随机分为A、B两组,A组予以甲强龙（甲强龙琥珀酸钠）40mg,静脉滴注,1次/d,同时配以低分子肝素治疗,B组予以泼尼松1mg/（kg·d）,晨起顿服,配以潘生丁50-75mg,3次/d。结果 A组治疗效果均优于B组（P〈0.05）,A组不良反应少于B组。结论 甲强龙＋低分子肝素治疗原发性肾病综合征起效快,疗效好,不良反应少。

Clinical Analysis of Primary Nephrotic Syndrome Methylprednisolone Therapy with Low Molecular Weight Hepa-rin

Objective To investigate the clinical efficacy of primary nephrotic syndrome methylprednisolone ＋ low molecular weight heparin. Methods 56 cases of patients with nephrotic syndrome were randomly divided into A, B groups, A group received methylprednisolone （methylprednisolone sodium succinate） 40mg once daily intravenous infusion, while accompanied by low molecular weight heparin therapy, group B to be prednisone 1mg /（ kg·d）, early morning Dayton clothing, with dipyri-damole 50mg-75mg, Tid, Po. Results A treatment group was better than group B （P〈0. 05）, A group of adverse reactions than group B. Conclusion methylprednisolone ＋ LMWH treatment of primary nephrotic syndrome rapid onset of efficacy, fewer adverse reactions.